Scouring sources for information on GLP1 Agonist drugs, so you don't have to.
drug:wegovy
FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or OverweightThe FDA approved a new use for a drug to reduce the risk of serious heart problems in adults with cardiovascular disease and either obesity or overweight.FDAOffice of the Commissioner In great
includes:study
Glucagon-Like Peptide 1 ("GLP1") is a naturally occurring hormone in the human body. GLP1 Receptor Agonists (ex. Semaglutide the formulation for Ozempic, Wegovy, and Rybelsus) aim to use modules similar to the naturally produced GLP1 in your body to trigger effects that contribute to better insulin management and
includes:study
Some recent research has been pointing to GLP1 as a usable tool in the fight against Cancer. ❗Worried about the possibility of GLP1 RAs causing cancer? We covered that in a previous article you might like to read. Cancer research is quite a popular point for funding, so it can
usecase:cancer
There have been worries in popular media about the possibility of GLP1 Receptor Agonists (drugs like Ozempic, Wegovy, Mounjaro, Zepbound and others) increasing the chance that people get cancer. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work? Check
drug:rybelsus
Rybelsus is a form of Semaglutide that you can take as a pill, rather than injection. If you're not familiar with Semaglutide, it's one of the GLP1 Receptor Agonist class of drugs that are taking the world by storm right now (Ozempic, Wegovy, and Rybelsus are
topic:faq
Both sound similar, and do similar things, but what is the difference? Well both of them are "incretin hormones", hormones that cause reductions in blood sugar: Incretin - WikipediaWikimedia Foundation, Inc.Contributors to Wikimedia projects Incretin hormones are important to weight loss and type 2 diabetes management because
One of the best things about the internet is the meeting of ideas. People discuss things, squabble, research, disagree, and we figure out just a little more about the truth. Recently I saw a great comment that gently suggested that insulin management is the real problem in weight loss. You
topic:insurance
You'd think that GLP1 Receptor Agonist treatments, which help treat type 2 diabetes and help with weight management (and thus avoid some bad potential outcomes like Heart Disease or Diabetes) would be loved by insurance companies. 🍃Don't know what a GLP1 Receptor Agonist is, or how
Pricing Roundups
Last updated: February 2024 Here's what we can find on pricing for GLP1 Receptor Agonists – Ozempic, Wegovy, Rybelsus, Zepbound, Mounjaro and more. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work? Check out our quick explainer Before
Research Roundups
GLP1 Receptor Agonist drugs (Semaglutide, Ozempic, Mounjaro, Wegovy, etc) have seen extensive testing and research in the past, due to their usage by people with type 2 Diabetes. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound work? Check out
A list of medical professionals and researchers from major universities and organizations: * Yale New Haven Health * Yale School of Medicine * Brigham and Women's Hospital * University of California, San Francisco Have petitioned the World Health Organization (WHO) to add GLP1 Receptor Agonists to the list of essential medicines for
Many opponents of GLP1 Receptor Agonist drugs (ex. Semaglutide, and Tirzepatide with brand names like Ozempic, Wegovy, Mounjaro, etc) caution that as the drugs must be taken continuously, people experience rapid weight gain after getting off the drugs – all the way up to their starting weight. 🍃Don't know